Read twice and referred to the Committee on Finance.
The SOAR Act of 2025 removes supplemental oxygen and related equipment from the Medicare competitive bidding program and sets new payment formulas beginning January 1, 2026. It creates special payment rules and a payment floor for liquid oxygen, establishes supplier responsibilities and beneficiary rights, adds reimbursement and a payment add-on for respiratory therapist services, requires electronic templates for medical necessity documentation, and mandates beneficiary notices about rental periods and grievance rights.
Access versus cost: left prioritizes access; right prioritizes cost control
Relative to its intended legislative type, this bill is a substantive policy change that is detailed in statutory amendments and operational mechanics.
The SOAR Act of 2025 removes supplemental oxygen and related equipment from the Medicare competitive bidding program and sets new payment formulas beginning January 1, 2026.
It creates special payment rules and a payment floor for liquid oxygen, establishes supplier responsibilities and beneficiary rights, adds reimbursement and a payment add-on for respiratory therapist services, requires electronic templates for medical necessity documentation, and mandates beneficiary notices about rental periods and grievance rights.
Several provisions require CMS rulemaking, stakeholder consultation, and periodic review.
Technically focused and beneficiary-friendly but increases Medicare spending; passage more plausible as part of a larger legislative vehicle than standalone.
Relative to its intended legislative type, this bill is a substantive policy change that is detailed in statutory amendments and operational mechanics. It specifies payment formulas, timing, supplier responsibilities, beneficiary protections, definitions, and program-integrity tools while delegating certain technical and pricing determinations to executive rulemaking and stakeholder consultation.
Access versus cost: left prioritizes access; right prioritizes cost control
These are examples from the analysis, not a ranked list of the most-affected groups.
Access versus cost: left prioritizes access; right prioritizes cost control
Generally supportive because the bill prioritizes patient access, supplier responsibilities, and beneficiary protections.
Views respiratory therapist reimbursement and stronger notice and grievance rights as improvements.
Concerned about possible increased Medicare spending and wants safeguards against overpayments and inequitable cost burdens for low-income beneficiaries.
Cautiously favorable to the access and patient-rights elements but concerned about cost and implementation.
Supports standardization of documentation and RT reimbursement, while wanting clear cost estimates, CBO scoring, and targeted safeguards to prevent overuse or waste.
Skeptical because removing competitive bidding and imposing payment floors risks higher Medicare costs and reduced market discipline.
Supports beneficiary choice and clearer supplier obligations but opposes non-budget neutral payments and expanded federal mandates on suppliers without budget offsets.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technically focused and beneficiary-friendly but increases Medicare spending; passage more plausible as part of a larger legislative vehicle than standalone.
The bill has not accumulated any surfaced votes yet.
Access versus cost: left prioritizes access; right prioritizes cost control
Technically focused and beneficiary-friendly but increases Medicare spending; passage more plausible as part of a larger legislative vehicl…
Relative to its intended legislative type, this bill is a substantive policy change that is detailed in statutory amendments and operational mechanics. It specifies payment formulas, timing, supplier responsibilities, b…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.